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SUMMARY: The phenomenon of "in vivo" blocking effect 
of antigen, due to the presence of rabies specific
neutralizing antibodies in previously vaccinated 
cattle, and its possible interference on the humoral 
immunologic response to revaccination was investigated 
in five zebu-crossbred bovines reared in field 
condition. The secondary vaccination was performed 180 
days from the first immunization, using a commercial 
inactivated rabies vaccine prepared in BHK-21 cells. 
Serum samples were taken sequentially after each 
vaccine adninistration at intervals of 0 (zero), 24 
and 72 hours, and after 7 and 14 days for the 
determination of neutralizing antibodies. The mean 
neutralizing antibody titer determined for sera taken 
iirmediately before the first vaccination was < 1:5, at
24 and 72 hours post-vaccination, < 1:6.25; the mean 
value found at 7 days post-vaccination was 1:144 ± 51; 
and 1:3,460 ± 1,329, at 14 days post-vaccination with 
mean titer of 1:58 ± 14; 24 hours after revaccination 
the mean titer was 1:129 ± 80, raising forwardly to 
1:277 ± 161, at 72 hours post-revaccination, and 
increasing levels > 1:6,400 and > 1:25,600 were found 
at 7 and 14 days post-revaccination, evidenciating a 
full anamnestic response. The blocking effect of 
antigen and the consequent fall in antibody levels 
shortly after the revaccination was not observed.
UNTTERMS: Rabies of cattle; Antibody formation;
Immunization; Immunity of cattle
INTRODUCTION
Epidemic pattern of rabies in cattle was first 
diagnosed by CARINI 8 (1911) in Santa Catarina State, 
Southern Brazil, and nearly a century ago the vampire 
bat-transmitted rabies is still prevalent in most of 
South and Central American Countries from Northern Ar­
gentina to Northern Mexico
Referring to the vampire bats, despite the wide 
variety of control methods currently available, they 
have been generally ineffective and, by and large the
non-selective methods of bat destruction have been
14
criticized by conservationists and ecologists 
Thus, vaccination has been used as an important alter­
native for controlling rabies in cattle, in order to 
minimize the ecnonomic losses due to this fatal 
disease.
To achieve this purpose, in the last 30 years
research has traditionally been conducted toward the
2
development of more effective and safer vaccines and
several live or inactivated vaccines became 
... ., . | , . 10,17,19
commercially available in this country '
A number of vaccines have experimentally been
demonstrated to be very effective for cattle
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' ' ' ' ' although in field conditions the
results were, in some occasions, very disappointing 
7,16,17
Insufficient potency of the vaccines
25 26
antigenic variants of the virus ' host nutrition
status and the antigenic stimulus 11, and other
factors like the interference of the specific passive
5 1c 21 22 c8
maternal antibody in young animals ' ' ' ' have 
been mentionned as the possible cause of the low 
protection revealed by such vaccines. In fact, ARNOLD 
et al. ^ (1973) have recoimended carefulness in 
vaccinating and revaccinating young calves born from 
dams immunized against rabies. According to these 
authors, calves possessing maternal antibodies should 
not be vaccinated until the age of seven months or 
until the passive immunity has wanned, a booster shot 
should be given six months later and subsequent annual 
revaccination should be adninistered cautiously.
In case of an enduring immunity following
vaccination, it has been suggested that injection of a
second dose of the same antigen when titer is still
detectable from the primary response results in
reduction rather than increase in serum antibody titer
due to removal of antibody in complex with antigen,
before the secondary immune response gets under way 
27
This phenomenon is the so-called "negative phase" 
and according to TIZZARD ^  (1977) in theory, it is 
similar to that observed in young calves passively 
protected by the specific' colostral antibodies, the 
presence of high levels of circulating antibodies may 
interfere with active immunization against the same 
antigen.
This "in vivo" neutralization is still a matter 
of controversy and needs further investigation in a 
scientifically controlled study, especially in cattle. 
The subject is important if revaccination has to be 
considered in herds presenting antibody titers above 
protective levels and reared in an endemic area where 
an emergency immunization is needed to rapidly protect 
the cattle against the disease.
The correlation between neutralizing antibodies 
and protection against challenge has raised some 
controversies in rabies, but as quoted by ATANASIU et 
al. 7 (1968) a relatively high neutralizing antibody 
level is generally accepted as an evidence of 
immunity.
The evaluation of the humoral immunity in those 
experiments involving different types of rabies 
vaccines has usually been conducted through the mouse 
serum neutralization (SN) test, a worldwide accepted 
assay method known to be very sensitive, although
9
CORTES; NILSSON (1974) recommended precaution in 
interpreting the results due to a high degree of
variability, since results change gradually over a 
wide range of virus doses used in the test system.
Based on the facts mentionned above, this work 
aims to investigate the phenomenon of the "in vivo" 
blocking effect of antigen by the serum antibodies 
remaining after its primary immune response. If the 
"negative phase" does occur as the response of the 
antigen binding and removing antibodies from the 
circulation, the SN test would detect the drop in the 
antibody levels for a few days before the 
establishment of an enduring secondary immune 
response.
MA TERIALS AND METHODS 
R A B I E S  V A C C I N E *
A commercially produced PV-strain adapted to BHK-
cell line and binary ethy leneimine (BEI) 
inactivated rabies vaccine, adjuvanted with 2% 
aluminum hydroxide (GUIDOLIN et al. 1983) was
given subcutaneously in a single dose of 5.0 ml per 
animal.
A N I M A L S
Cattle - The bovines used in this study were derived 
from a ranch located in the State of São Paulo, known 
to be free of rabies and not practicing vaccination 
against rabies. Five female Zebu cattle of Nelore 
breed aged between 12 to 36 months were selected after 
screening through the mouse SN test at 1:5 dilution.
Mice - Swiss albino mice used in the SN test were 
derived from a laboratory animal breeding station 
maintained at Santa Isabel - SP by Pfizer, weighing 
between 10 to 14 grams and divided into groups of five 
mice each. Groups of 10 mice each were used for the 
CVS (Challenge Virus Standard) strain virus titration.
Virus - The CVS strain 31/2 of fixed rabies virus from 
Pan American Zoonoses Center (CEPANZO), Argentina, was 
used for the SN test. The virus had been maintained in 
mice through two additional intracerebral inoculation 
and the LD^q (MICLDgg) determined was 10 '*'^/0.03 ml.
Equine sera - Rabies hyperimmune serum - This serum was 
kindly provided by the Butantan Institute - São Paulo,
SP, and used as the positive control serum for the SN 
test.
•Rabies vaccine: RABVAC, Pfizer Co.Ltd., Guarulhos - 
SP, Brazil.
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Equine normal serum - Previously tested by SN test, free 
of antibody against rabies, this foal serum was used 
for the preparation of the diluent at a concentration 
of 2% (V/V) in distilled uater containing 1.000 IU of 
Penicillin and 1.25 mg of Streptomycin per ml.
Mouse serum neutralization (SN) test - The test carried out 
was the constant virus - varying serum dilution method 
and the procedures adopted were described by ATANASIU
6 , 1976.
EXPERIMENTAL PROCEDURE
Five cattle were given subcutaneousIy 5.0 ml of 
rabies vaccine at the beginning of the experiment (day 
zero) immediately after the initial bleeding, blood 
collections were then sequentially performed at the 
1st, 3rc*, 7 1*1 and 1 4 ^  day post initial vaccination 
(DPIV). The revaccination was carried out at 1 8 0 ^  day 
after the primary vaccination using the same type of 
vaccine and dose.
Bleedings were made shortly before the 
actninistration of the second vaccine shot and repeated 
subsequently as described for the first vaccination.
Serum samples taken at each bleeding days were 
stored at -20 °C until required. After thawing, the 
sera were inactivated at 56 °C for 30 minutes and then 
submitted to SN test. The antibody titration was run 
twice, all samples not having determined the 50% end 
dilution at the first titration were tentatively 
assessed for the second time, using the two-fold 
serial dilutions and the final dilution of the serum- 
virus mixture ranged from 1:6.25 to 1:25,600. Control 
serum was also diluted by using two-fold serial 
dilutions, each dilution was then inoculated 
intracerebral ly into five mice each.
The mice were observed dail^ for 21 days and only 
the mice found dead from the 4 day post inoculation 
were considered for the titer confutation, which was 
made accordingly to REED; MUENCH  ^ (1938). The titers 
were expressed as the reciprocal of dilutions 
protecting 50% of the inoculated mice.
RESULTS
The time course of the humoral immune response 
of five cattle to inactivated rabies vaccine, 
enabled by bleeding at intervals of zero, 1,3,7 
and 14 days after primary vaccination and their 
respective values in titers of neutralizing 
antibody are surrmarized in Tab. 1. At day zero, all 
five animals were found with their SN titers < 1:5 and 
at 2nc* and 3 rc* DPIV the titers determined were <
1:6.25. The antibody titers corresponding to 7th DPIV 
the values found ranged from 1:31 to 1:199, with a 
mean titer of 1:144 ± 51. The mean SN titer found in 
the serum sampLes taken at 14th DPIV was 1:3,460 t
1,329; indicating a mean rise in SN titer of 24 times 
within a week. By the profiles of the primary hunoral 
immune response, increasing levels of antibodies were 
noted until 14 DPIV; animal n s 16 presented lower 
antibody response than did the others, i.e., 1:31 and 
1:504, respectively at 7 and 14 DPIV.
The bleeding of five animals carried out on 
day 180 confirmed the presence of the remaining 
serum neutralizing antibodies following the primary 
immune response; the SN titers ranged from 1:26 
to 1:70 with a mean titer of 1:58 ± 14, as are 
summarized in Tab. 2.
Serum samples taken 24 hours following 
revaccination were slightly increased in their SN 
titers with a mean titer of 129 ± 80. At this time 
interval, although statistically not significant, a 
drop of two units in titer was detected in the serun 
of animal n s 33, and animal n s 16 maintained its titer 
of 1:62, whilst the antibody titers of other three 
animals have increased in terms of their absolute 
values, titers corresponding to two heifers were found 
to be increased 3.7 times within 24 hours.
From day 3 after the revaccination the levels of 
the serum neutralizing antibodies tended to elevate 
rapidly with the mean titer of 1:277 ± 161 and the 
mean rise in titer was 2.14 times. Serum samples 
corresponding to 7 th DPR were not determined their 
final 50% end dilutions but they were found to be 
greater than 1:6,400, except animal n s 16 with a titer 
of 1:4,525. Similar results were found for sera 
corresponding to 14th DPR, their 50% end dilutions 
were not determined but animal n s 16 with a titer of 
1:4,530.
DISCUSSION
In the sera of cattle given a commercially 
produced rabies inactivated vaccine, detectable amount 
of specific antibodies could not be found for several 
days after the primary vaccination. This is known as 
the "lag period", according to TIZARD 1977.
Although the time course of the immune response was 
not followed at daily intervals, serun neutralizing 
antibodies were already detectable at 7 t 1^ DPIV, which 
are in accordance to many of the previous works 
reported elsewhere.
The response of cattle given a second dose of the 
same vaccine six months later was very different from 
the first in that it occurs much more rapidly and the 
serum neutralizing titers reach higher levels. The so-
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called "lag period" tended to be very transient or 
undetectable.
The mean titer corresponding to this time point,
i.e., 1st DPR, has increased from 58 ± 14 to 129 ± 80
within 24 hours, indicating that the drop in the level
of antibodies due to "in vivo" blocking effect did not
occur. In fact, the adjuvant contained in the vaccine
may have influenced the processing of antigen by the
antigen sensitive cells, slowing the rate of antigen
release from the vaccine depot and consequent
degradation. When the antigen was directly
24
adninistered through intravenous route, UHR et al.
20
(1962) and SVEHAG; MANDELL (1964) reported the 
phenomenon of "negative phase" due to the excess of 
serum antibodies.
The antibody levels of 1:62 and 1:24, 
respectively derived from sera of animal n s 16 and n s
St
33 taken at 1 DPR, when compared to the values 
corresponding to those of 180 DPR are not 
statistically different, indicating clearly that the 
"negative phase" did not occur. However, in spite of 
the high sensitivity of the mouse SN test used in this 
experiment, this method of antibody quantitation 
involves assay in living system and the reactions are 
subejected to a high degree of variability; the 
results tend to change gradually over a wide range of 
doses of the virus and, as suggested by CORTES; 
NILSSON (1974), they must be interpreted carefully. 
Based on the analysis of the overall results, we are 
inclined in not accepting the phenomenon of "negative 
phase" to occur with the vaccine used.
Another fact clearly demonstrated in this study 
was the velocity in the rising of the antibody titers 
after the presentation of the second dose of the same 
vaccine; the memory cells as well as the effector 
cells of the cel I-mediated iumune response must have
effectively been triggered by the vaccine. SVEHAG;
20
MANDEL (1964) reported that the duration of
antibody synthesis is related to dose of antigen; high 
dose gives enduring response and antibody population 
consisted of IgM and IgG; IgM synthesis proceded IgG 
by one to two days. UHR; BAUMANN 23 (1961) reported 
that IgM synthesis has short-lasting immunologic 
memory but in the presence of high doses, the 
effective anamnestic response is associated only with 
IgG.
Analyzing the serum neutralizing antibody profile 
of animal n* 16 it seems that the rise in the level of 
antibodies tended to a plateau; this could be due to 
an individual difference in responding to an antigen 
stimulus rather than antigen exhaustion. The ideal 
scheme for the vaccination of young calves, however, 
is still lacking and needs further investigation.
The anamnestic immune response was fully 
confirmed, corroborating the findings of other authors
that have investigated different types of rabies 
vaccines. This is of epidemiological importance, 
especially in situation when Agricultural Authorities, 
field practitioners and cattle farmers must intervene 
rapidly and effectively to control the focus of this 
lethal disease.
ITO, F.H.; CORTES, J.A.; RWEYEMAMU, M.M.; UMEHARA, 0.; 
MEDEIROS NETO, R.; DE LUCCA NETO, D.; BALTAZAR, M.; 
VASCONCELLOS, S.A.; VASCONCELLOS, M.E.P. Perfil da 
resposta imune humoral de bovinos após a revacinação 
com vacina anti-rábica inativada, preparada em 
células BHK contendo Hidróxido de Alumínio. Braz. J. 
vet. Res. anim. Sei. , São Paulo, v.28, n.1, p.51-7, 1991.
RESUMO: O fenômeno do consumo de antígeno, devido à 
presença de anticorpos neutralizantes específicos para 
a raiva, em bovinos previamente vacinados e a sua 
possível interferência na resposta imunológica 
humoral, decorrente de revacinação, foi investigado em 
cinco bovinos mestiços azebuados, criados em condições 
de campo. A revacinação foi realizada 180 dias após a 
primeira aplicação, utilizando uma vacina comercial 
inativada, preparada em células BHK-21. As amostras de 
soros foram obtidas em intervalos seqüenciais de 0 
(zero), 24 , 72 horas, sete e 14 dias, em cada 
vacinação e foram submetidas à prova de neutralização 
em camundongos para a pesquisa de anticorpos. 0 título 
médio de anticorpos neutralizantes, encontrado para o 
momento imediatamente antes da primeira vacinação foi 
< 1:5,24 e 72 horas após a vacinação foi < 1:6,25; no 
sétimo dia pós-vacinação o valor médio foi de 1:144 ± 
51; aos 14 dias pós-vacinação, 1:3.460 ± 1.329. Todos 
os animais apresentaram títulos detectáveis no 180a 
dia pós-vacinação, com um valor médio de 1:58 ± 14; no 
entanto, 24 horas após a dose revacinante, foi 
detectado um valor médio de 1:129 ± 80, ascendendo 
para 1:277 ± 161 no 3 S dia pós-revacinação, e níveis 
crescentes no 7 ! e no 14! dia pós-revacinação, com 
valores, respectivamente, superiores a 1:6.400 e 
1:25.600, indicando o estabelecimento de uma resposta 
anamnéstica plena. Não foi obervado o efeito do 
consumo do antígeno e a conseqüente diminuição nos 
títulos de anticorpos, imediatamente após a 
revacinação.
UN1TERMOS: Raiva, bovinos; Anticorpos, formação;
Imunização; Imunidade, bovinos
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TABLE 1 - Antirabies serum neutralizing antibody titers shortly before 
and after vaccination of cattle with BHK-21 cell culture 
inactivated rabies vaccine. São Paulo, 1988.
Animal Neutralizing Antibody Titers*
Number Day 0 lSt DFV** 3rd DFV 7th DFV 14thDFV
10 < 5 < 6.25 < 6.25 141 4,150
16 < 5 < 6.25 < 6.25 31 504
17 < 5 < 6.25 < 6.25 178 4,525
19 < 5  < 6 . 2 5  < 6 . 2 5  170 4,592 
33 < 5 < 6.25 < 6.25 199 4,530
Arithmetic mean ... ... 144 3, 460
Variance ... ... 3 527 2, 302,117
Standard deviation ... ... 59 1, 517
Mean standard error ... ... 26 678
Confidence interval ... ... 93 I -I 195 2,131 M 1 W ■
C- <o 00
* Reciprocal of neutralizing antibody dilution, using CVS strain of fixed
rabies virus with 30 mouse ID^g/0.03 ml 
** Day Post Vaccination 
§ Confidence interval, 0! = 0.05 
... Not determined
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TABLE 2 - Antirabies serum neutralizing antibody titers shortly before 
and after revaccination of cattle at 180 days with BHK-21 cell 
culture inactivated rabies vaccine. São Paulo, 1988.
Animal
Number 1 8 0 ^  day
Neutralizing 
lSt DPR**
Antibody
„rd
3 DPR
Titers*
_ th , ,
7 DPR
■ ,th . ,, 
14 DPR
10 67 80 308 > 6,400 > 25,600
16 62 62 79 4,525 4,530
17 67 224 356 > 6,400 > 25,600
19 70 259 565 > 6,400 > 25,600
33 26 24 80 > 6,400 > 25,600
Arithmetic mean 
Variance
Standard deviation 
Mean standard error 
Confidence interval
58
26S
16
7
44 I-I 72
129
8,767
93
41
44 I-I 209
277
33,489
183
82
116 I-I 438
* Reciprocal of neutralizing antibody dilution, using CVS strain of fixed 
rabies virus with 30 mouse ID^ q /0.03 ml
** Day Post Revaccination 
§ Confidence interval, OL = 0.05 
... Not determined
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